i2E scores a win for state in Oklahoma, leverages $23M in additional capital
We had the opportunity to showcase innovation 2 Enterprise in a web-workshop earlier this year, a Oklahoma state supported POC/seed stage accelerator/investor. They recently reported a major success in leverging $23 M for Selexys Pharma and MPM Capital to sickle cell and Crohn’s drugs. Pending a successful trial there could be a payout of nearly […]